Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;58(2):206-15.
doi: 10.1007/s12630-010-9429-7. Epub 2010 Dec 31.

GABA(A) receptors as molecular targets of general anesthetics: identification of binding sites provides clues to allosteric modulation

Affiliations
Review

GABA(A) receptors as molecular targets of general anesthetics: identification of binding sites provides clues to allosteric modulation

Richard W Olsen et al. Can J Anaesth. 2011 Feb.

Abstract

Purpose: The purpose of this review is to summarize current knowledge of detailed biochemical evidence for the role of γ-aminobutyric acid type A receptors (GABA(A)-Rs) in the mechanisms of general anesthesia.

Principal findings: With the knowledge that all general anesthetics positively modulate GABA(A)-R-mediated inhibitory transmission, site-directed mutagenesis comparing sequences of GABA(A)-R subunits of varying sensitivity led to identification of amino acid residues in the transmembrane domain that are critical for the drug actions in vitro. Using a photo incorporable analogue of the general anesthetic, R(+)etomidate, we identified two transmembrane amino acids that were affinity labelled in purified bovine brain GABA(A)-R. Homology protein structural modelling positions these two residues, αM1-11' and βM3-4', close to each other in a single type of intersubunit etomidate binding pocket at the β/α interface. This position would be appropriate for modulation of agonist channel gating. Overall, available information suggests that these two etomidate binding residues are allosterically coupled to sites of action of steroids, barbiturates, volatile agents, and propofol, but not alcohols. Residue α/βM2-15' is probably not a binding site but allosterically coupled to action of volatile agents, alcohols, and intravenous agents, and α/βM1-(-2') is coupled to action of intravenous agents.

Conclusions: Establishment of a coherent and consistent structural model of the GABA(A)-R lends support to the conclusion that general anesthetics can modulate function by binding to appropriate domains on the protein. Genetic engineering of mice with mutation in some of these GABA(A)-R residues are insensitive to general anesthetics in vivo, suggesting that further analysis of these domains could lead to development of more potent and specific drugs.

Objectif: L’objectif de cet article de synthèse est de résumer les connaissances actuelles concernant les données probantes biochimiques détaillées élucidant le rôle des récepteurs à l’acide γ-aminobutyrique de type A (R-GABAA) dans les mécanismes de l’anesthésie générale.

Constatations principales: Tous les anesthésiques généraux modulent positivement la transmission inhibitrice médiée par les R-GABAA. On a identifié les acides aminés du domaine transmembranaire représentant des sites d’action importants des médicaments, en effectuant des mutations ciblées sur des séquences de sous-unités des R-GABAA et en comparant leur sensibilité. À l’aide d’un analogue photo luminescent de l’anesthésique général étomidate R(+), nous avons identifié deux acides aminés transmembranaires marquées par affinité dans les R-GABAA purifiés de cerveau bovin. Un modèle structurel de protéine par homologie place ces deux résidus, soit αM1-11’ et βM3-4’, à proximité l’un de l’autre dans un type unique de poche de liaison d’étomidate inter-sous-unité au niveau de l’interface β/α. Cette position sera adaptée pour moduler le portillon des canaux agonistes. Globalement, les données disponibles suggèrent que des deux résidus se liant à l’étomidate sont couplés de façon allostérique aux sites d’action des stéroïdes, des barbituriques, des agents volatils et du propofol, mais pas à ceux des alcools. Le résidu α/βM2-15’ n’est probablement pas un site de liaison, mais il est couplé de façon allostérique à l’action des agents volatils, des alcools et des agents intraveineux, et le α/βM1-(-2’) est couplé à l’action des agents intraveineux.

Conclusion: La création d’un modèle structurel cohérent et logique des R-GABAA appuie notre conclusion selon laquelle les anesthésiques généraux peuvent moduler leur fonction en se liant à des domaines spécifiques sur la protéine. Les souris génétiquement modifiées porteuses d’une mutation dans certains de ces résidus de R-GABAA ne sont pas sensibles aux anesthésiques généraux in vivo, ce qui suggère qu’une analyse plus approfondie de ces domaines pourrait permettre la mise au point de médicaments à la fois plus puissants et plus spécifiques.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Three-dimensional views of the γ-aminobutyric acid type A receptors (GABAAR) homology model from different perspectives (A,B) and helical wheel representation of the transmembrane regions at the etomidate binding domain at the β/α interface (C). A) Three-dimensional view of the GABAAR homology model (β3, cyan; α1, yellow; γ2, green) from a perspective outside the membrane looking down the channel or B) from a perspective parallel to the membrane surface. Modified from Li et al. (2006) in which our homology model is based roughly on the nicotinic acetylcholine receptor cryo-EM derived structure (PDB:2BG9), modified by helical alignment data from Jansen & Akabas (2006). Pockets in the vicinity of the etomidate (maroon), GABA (purple), and benzodiazepine (red) binding sites are shown as Connolly surfaces. C) Helical wheel representation of the GABAAR β/α interface in the trans-membrane domain illustrating the proposed binding site for etomidate (modified from Li et al., 2009). The model illustrates the orientation of residues from a homology model built on the nicotinic acetylcholine receptor cryo-EM derived structure, with the residues in αM1 and βM3 photolabelled by [3H]azietomidate (circled residues in green) contributing to a common binding pocket at the β/α interface. Also included: the position in βM2 (N265) that functions as a determinant of etomidate/azietomidate anesthetic potency in vivo (pink),,; the residues in αM1 and βM3 identified as sensitivity determinants for direct activation by neurosteroids (boxed residues in yellow); and the positions in αM1 and βM3 that can form intersubunit cross-links when mutated to Cys (red and orange),
Fig. 2
Fig. 2
The intersubunit anesthetic binding pocket in the γ-aminobutyric acid type A (GABAA) receptor transmembrane domain identified by photoaffinity labelling with [3H]azietomidate. The identified residue, M236, in the M1 domain of the α subunit is situated nearly adjacent to the identified residue, M286, in the M3 domain of the β subunit. Reproduced with permission from: Li GD, Chiara DC, Sawyer GW, Hussain SS, Olsen RW, Cohen JB. Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabelling with an etomidate analog. J Neurosci 2006; 45: 11599-605

Similar articles

Cited by

References

    1. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med. 2003;348:2110–2124. doi: 10.1056/NEJMra021261. - DOI - PubMed
    1. Hemmings HC, Jr, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL. Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci. 2005;26:503–510. doi: 10.1016/j.tips.2005.08.006. - DOI - PubMed
    1. Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nature Rev Neurosci. 2008;9:370–386. doi: 10.1038/nrn2372. - DOI - PubMed
    1. Macdonald RL, Olsen RW. GABAA receptor channels. Ann Rev Neurosci. 1994;17:569–602. - PubMed
    1. Luddens H, Korpi ER, Seeburg PH. GABAA/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology. 1995;34:245–254. doi: 10.1016/0028-3908(94)00158-O. - DOI - PubMed